Cargando…

Genetic Architecture of Familial Hypercholesterolaemia

PURPOSE OF REVIEW: Familial hypercholesterolaemia (FH) is an inherited disorder of low-density lipoprotein cholesterol (LDL-C) which is characterised by a raised cholesterol level from birth and a high risk of premature coronary heart disease. In this paper, we review the genetic basis of FH and its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharifi, Mahtab, Futema, Marta, Nair, Devaki, Humphries, Steve E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389990/ https://www.ncbi.nlm.nih.gov/pubmed/28405938 http://dx.doi.org/10.1007/s11886-017-0848-8

Ejemplares similares

Polygenic Hypercholesterolemia and Cardiovascular Disease Risk
por: Sharifi, Mahtab, et al.
Publicado: (2019)

Optimizing Treatment of Familial Hypercholesterolemia in Children and Adolescents
por: Luirink, Ilse K., et al.
Publicado: (2015)

New Approaches in Detection and Treatment of Familial Hypercholesterolemia
por: Hartgers, Merel L., et al.
Publicado: (2015)

Contributions of Interactions Between Lifestyle and Genetics on Coronary Artery Disease Risk
por: Said, M. Abdullah, et al.
Publicado: (2019)

Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug Therapy
por: Wiklund, Olov, et al.
Publicado: (2013)

Prevention of Hypertensive Disorders of Pregnancy: a Novel Application of the Polypill Concept
por: Browne, J. L., et al.
Publicado: (2016)

Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
por: Dallinga-Thie, Geesje M., et al.
Publicado: (2016)

Progressing Insights into the Role of Dietary Fats in the Prevention of Cardiovascular Disease
por: Zock, Peter L., et al.
Publicado: (2016)

Lipid Screening, Action, and Follow-up in Children and Adolescents
por: Wiegman, Albert
Publicado: (2018)

HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?
por: Karalis, I., et al.
Publicado: (2018)

Strengths and Limitations of Using the Polypill in Cardiovascular Prevention
por: Roy, Ambuj, et al.
Publicado: (2017)

Management of Lipid Abnormalities in Patients with Diabetes
por: Sillars, Anne, et al.
Publicado: (2019)

Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia
por: Pears, Robert, et al.
Publicado: (2015)

Reasons Why Combination Therapy Should Be the New Standard of Care to Achieve the LDL-Cholesterol Targets: Lipid-lowering combination therapy
por: Masana, Lluís, et al.
Publicado: (2020)

Cardiovascular risk stratification in familial hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2016)

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
por: Tandirerung, Fistra Janrio
Publicado: (2022)

Familial Hypercholesterolemia: Present and Future Management
por: Sjouke, B., et al.
Publicado: (2011)

Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities
por: Epstein, Elizabeth, et al.
Publicado: (2021)

PCSK9 Inhibitor Wars: How Does Inclisiran Fit in with Current Monoclonal Antibody Inhibitor Therapy? Considerations for Patient Selection
por: Arnold, Natalie, et al.
Publicado: (2022)

Is Lipoprotein(a) Clinically Actionable with Today’s Evidence? The Answer is Yes
por: Ma, Gary S., et al.
Publicado: (2023)

Case-finding and genetic testing for familial hypercholesterolaemia in primary care
por: Qureshi, Nadeem, et al.
Publicado: (2021)

Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia
por: Futema, Marta, et al.
Publicado: (2012)

Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care
por: Qureshi, Nadeem, et al.
Publicado: (2021)

Investigating the use of ultrasonography for the antenatal diagnosis of structural congenital anomalies in low-income and middle-income countries: a systematic review
por: Goley, Stephanie Michele, et al.
Publicado: (2020)

Novel facial characteristics in congenital rubella syndrome: a study of 115 cases in a cardiac hospital of Bangladesh
por: Begum, Nurun Nahar Fatema
Publicado: (2020)

Prevalence of microcephaly: the Latin American Network of Congenital Malformations 2010–2017
por: Morris, Joan, et al.
Publicado: (2021)

Risk factors for hospitalisation in Welsh infants with a congenital anomaly
por: Ho, Peter S Y, et al.
Publicado: (2022)

Risk factors for death in Welsh infants with a congenital anomaly
por: Ho, Peter S Y, et al.
Publicado: (2021)

Birth prevalence of encephalocele in Africa: a systematic review and meta-analysis
por: Oumer, Mohammed, et al.
Publicado: (2021)

Gastrostomy and congenital anomalies: a European population-based study
por: Garne, Ester, et al.
Publicado: (2022)

Effectiveness of penile ventral curvature correction and the trend of hypospadias repair: a prospective study of the national center in China
por: Yang, Zhenzhen, et al.
Publicado: (2023)

Causes of death in children with congenital anomalies up to age 10 in eight European countries
por: Rissmann, Anke, et al.
Publicado: (2023)

Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC)
por: Futema, Marta, et al.
Publicado: (2017)

Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations
por: Futema, Marta, et al.
Publicado: (2014)

Identification of Plant-like Galactolipids in Chromera velia, a Photosynthetic Relative of Malaria Parasites
por: Botté, Cyrille Y., et al.
Publicado: (2011)

Purification, Identification, and Cloning of Lysoplasmalogenase, the Enzyme That Catalyzes Hydrolysis of the Vinyl Ether Bond of Lysoplasmalogen
por: Wu, Lai-Chu, et al.
Publicado: (2011)

Antioxidant-rich spice added to hamburger meat during cooking results in reduced meat, plasma, and urine malondialdehyde concentrations(1)(2)(3)(4)
por: Li, Zhaoping, et al.
Publicado: (2010)

A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis
por: He, Shaoqing, et al.
Publicado: (2010)

Identification and Structure Determination of Novel Anti-inflammatory Mediator Resolvin E3, 17,18-Dihydroxyeicosapentaenoic Acid
por: Isobe, Yosuke, et al.
Publicado: (2012)

Randomized controlled study of the effect of a butter naturally enriched in trans fatty acids on blood lipids in healthy women(1)(2)(3)
por: Lacroix, Émilie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gup36s6sqo5cno5g32lc8nu5c4